Daniel G McGarry

Title: The Innovations of Daniel G McGarry

Introduction

Daniel G McGarry is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit useful pharmacological activity. With a total of four patents to his name, McGarry's work focuses on innovative solutions for medical disorders.

Latest Patents

Among his latest patents is a formulation involving substituted sulfonic acid. The compounds of formula I are designed to inhibit the activity of Factor Xa, which plays a crucial role in blood coagulation. These compounds are incorporated into pharmaceutical compositions aimed at treating patients suffering from various medical conditions. The invention emphasizes the therapeutic potential of these compounds in ameliorating physiological conditions through the administration of Factor Xa inhibitors.

Career Highlights

Daniel G McGarry has been associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has contributed to groundbreaking research and development in the pharmaceutical industry. His expertise in pharmacology and innovative thinking has led to advancements that benefit patient care and treatment options.

Collaborations

Throughout his career, McGarry has collaborated with esteemed colleagues, including John R Regan and Michael N Chang. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Daniel G McGarry's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving medical treatments. His work continues to impact the lives of patients and the pharmaceutical industry positively.